In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Role of Integrated approach of pharmacological plus non pharmacological therapy in severe chronic heart failure patients.

Session Poster Session 1

Speaker Naresh Sen

Event : Heart Failure 2018

  • Topic : heart failure
  • Sub-topic : Chronic Heart Failure: Clinical, Other
  • Session type : Poster Session

Authors : N Sen (Jaipur,IN), SONAL Tanwar (Jaipur,IN), ASHOK Jain (Jaipur,IN)

N Sen1 , SONAL Tanwar2 , ASHOK Jain1 , 1Narayana Hrudayalaya, Cardiology - Jaipur - India , 2HG SMS Hospital, Cardiology - Jaipur - India ,


Background: Studies revealed non pharmacological therapy consisting of yoga, meditation ,exercise and education training, in combination with diet counselling ,stress management , Enhanced external counter pulsation machine (EECP) have good role to prevent worsening heart failure

Aim: Integrative program with focus on Integrated Medicine with life style intervention in patients with severe chronic heart failure and beneficial outcome of integrated approach. 

Methods: The Observational study a 3-year outpatient : A total of 202 middle-aged men and women, chronic heart failure with Hypertension, dyslipidemia, type 2 Diabetes mellitus and obesity were enrolled. The usual care (routine allopath medicines) group A(n=106)  and the integrated approach( allopathy plus non pharmacological ) with life style interventional group B (n=96).  For Group B- Education, Exercise: supervised endurance and yoga , meditation with restricted diet and aerobics: three times a week for three months with Enhanced external counter pulsation machine (EECP) four cycle weekly for 5 months . 

Results: Proposed lifestyle improved after year 3 in the  group A over group B. There were significant differences between groups, mean changes (and  their 95% confidence intervals, CI) in waist circumference  pv0.001),  in waist–hip ratio  p<0.01) , decrease in HR (p<0.01), systolic BP (p<0.01) and diastolic BP(p<0.05) blood cholesterol and sugar, HBA1C level . Recurrent hospitalization with congestive heart failure (CHF) in group A =23/106, group B =7/96( p<0.03) . Atrial fibrillation in group A =12/106, group B =3/96 (p<0.08).Ventricular tachycardia in group A =8/106, group B =3/96( p<0.23). Death in group A =18/106, group B =6/96( p<0.36).Post MI-CHF in group A =9/106, group B =3/96( p< 0.36). Post CABG-CHF in group A= 8/106, group B=2/96. 

Conclusion: Regular 3-year follow-up improvements in quality of life, decrease stress, decrease incidence of cardio-vascular events , improve Exercise Score, better reduction of heart rate, blood pressure, weight, waist circumference, three to four time decrease episodes  of recurrent hospitalization , Cardiac Arrhythmias and 33% reduction of cardiovascular mortality in integrated group as compare to usual group.

The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are